KWANG-SUNG AHN
KWANG-SUNG AHNPh.D. CEO
Disease prognostic Minner

CEO of PDXen Biosystems Co.

  • MAJOR IN Oncology Biology and Oncology Genetics

  • Ph.D. (University of Houston)

  • Post-doc (UCLA)

  • Senior Researcher (Samsung Biomedical Research Institute, SBRI)

  • Research Professor of Pathology, Korea University College of Medicine

  • Research Professor, Cancer Research Institute, Seoul National University College of Medicine

2019

01　Registration of Animal laboratory Facilities

2018

11　Establishment of Seoul Branch
11　Registration of PDXen Institutional Review Board (IRB)
07　Investment attraction from Individual Investors
04　Selected as Korea Engineering Service Provider (K-ESP)
01　Established of Pangyo Branch in Pangyo 2nd Techno Valley Enterprise Support Hub Center

2017

11　Registered as a Research Institute of ETRI (No. 500)
10　Moved the head office to ETRI Convergence Technology Commercialization Center
10　Investment attraction from ETRI and ETRI Holdings Co
09　Certification of Research and Development Services

2016

01　Registration of Animal laboratory Facilities

2015

01　Registration of Animal laboratory Facilities

2014

01　Registration of Animal laboratory Facilities

2013

10　주식회사 피디젠 벤처기업 인증
09　주식회사 피디젠 설립

Research

Ut convallis, magna sed dapibus tincidunt, nulla lacus sollicitudin nisi, id commodo

READ LATEST RESEARCH

Discovery

Ut convallis, magna sed dapibus tincidunt, nulla lacus sollicitudin nisi, id commodo

ABOUT OUR APPROACH

Analysis

Ut convallis, magna sed dapibus tincidunt, nulla lacus sollicitudin nisi, id commodo

DATA-DRIVEN SOLUTIONS

Testing

Ut convallis, magna sed dapibus tincidunt, nulla lacus sollicitudin nisi, id commodo

LEARN ABOUT OUR TESTING

Discover The Future

We are a multi-disciplinary laboratory committed to focussed and efficient drug discovery.